Partell Specialty Pharmacy (One Way Drug, LLC), Las Vegas, NV
Is Partell Specialty Pharmacy (One Way Drug, LLC) registered with the FDA as a 503B outsourcing facility?
No matching record found in FDA’s registered outsourcing facility list (updated Nov 6, 2026) on Nov 15, 2026, searching by name and location. FDA’s compounding inspections and actions page labels it a 503A facility.
Does Partell Specialty Pharmacy (One Way Drug, LLC) hold a Nevada pharmacy license?
State board of pharmacy records for Nevada are not checked: no license file or list of board actions was found on the board’s website when checked on November 10, 2026 (it takes requests for discipline records); its license verification is an interactive search. The Texas State Board of Pharmacy also lists nonresident license 26369 for PARTELL SPECIALTY PHARMACY, LAS VEGAS, NV, status Revocation, as of Nov 15, 2026. The Colorado State Board of Pharmacy also lists nonresident license OSP 6350 for Partell Specialty Pharmacy, Las Vegas, NV, status Expired and license OSP 6351 for Partell Specialty Pharmacy, Las Vegas, NV, status Expired, as of Nov 15, 2026. The Illinois Department of Financial and Professional Regulation also lists nonresident license 054018733 for ONE WAY DRUG LLC, LAS VEGAS, NV, status CHANGE OF OWNERSHIP, license 054018734 for ONE WAY DRUG LLC, LAS VEGAS, NV, status CLOSED, license 054020497 for ONE WAY DRUG LLC, LAS VEGAS, NV, status NOT RENEWED and license 054020655 for ONE WAY DRUG LLC, LAS VEGAS, NV, status NOT RENEWED, as of Nov 13, 2026. The Connecticut Department of Consumer Protection also lists nonresident license PCN.0002710 for PARTELL SPECIALTY PHARMACY, LAS VEGAS, NV, status INACTIVE and license PCN.0003345 for ONE WAY DRUG LLC (dba PARTEL SPECIALTY PHARMACY), LAS VEGAS, NV, status INACTIVE (EXPIRED MORE THAN 3 YEARS - MUST REAPPLY), as of Nov 15, 2026. The Delaware Division of Professional Regulation also lists nonresident license A9-0002064 for Partell Specialty Pharmacy, LAS VEGAS, NV, status Closed, as of Nov 10, 2026.
Has Partell Specialty Pharmacy (One Way Drug, LLC) had a state board action or FDA letter?
FDA letters: record found. FDA’s compounding inspections and actions page, current as of Oct 22, 2026, lists 1 warning letter (Mar 13, 2019), 1 warning letter close-out (Jun 16, 2020), 1 state referral letter (Jun 16, 2020) and 1 FMD-145 letter (Jun 16, 2020) for Partell Specialty Pharmacy (One Way Drug, LLC). State board of pharmacy records for Nevada are not checked: no license file or list of board actions was found on the board’s website when checked on November 10, 2026 (it takes requests for discipline records); its license verification is an interactive search. The Colorado State Board of Pharmacy’s license dataset also lists “CLS Letter of Admonition” dated Apr 22, 2026, case 2025-5663 on nonresident license OSP 6351. The state referral and handoff letters above are FDA’s letters to the state, not board actions.
FDA registers 503B outsourcing facilities; state boards of pharmacy license pharmacies, including 503A compounding pharmacies, and keep their own disciplinary records. Neither FDA list says which drugs a pharmacy makes.
- Names in FDA records
- One Way Drug, LLC; Partell Specialty Pharmacy
- Location
- Las Vegas, NV
- Type as FDA labels it
- 503A
- FDA 503B list
- No matching record found
- Form 483s on FDA’s actions page
- 1
- Warning letters on FDA’s actions page
- 1
- Latest action on that page
- Jun 16, 2020
- FDA Data Dashboard inspections
- 2 inspections: 2 OAI; 2 published Form 483s
- Form 483 text on this page
- 1 Form 483, 3 observations
- State board records
- Not checked
FDA inspections and letters
FDA’s compounding inspections and actions page (current as of Oct 22, 2026) lists this pharmacy as One Way Drug, LLC, (dba Partell Specialty Pharmacy), a 503A facility, with 5 dated actions.
| Document | |||
|---|---|---|---|
| Jun 16, 2020 | State referral letter | State Referral Letter Issued 06/16/2020 | Not linked by FDA |
| Jun 16, 2020 | FMD-145 letter | FMD-145 Letter Issued 6/16/2020 | FDA copy (archived) |
| Jun 16, 2020 | Warning letter close-out | Warning Letter Close Out Issued 06/16/2020 | Not linked by FDA |
| Nov 25, 2019 | Form 483 | 483 Issued 11/25/2019 | fda.gov |
| Mar 13, 2019 | Warning letter | Warning Letter (03/13/2019) | fda.gov |
A Form 483 lists investigator observations, not a final FDA determination. A warning letter states FDA’s view when it was issued, not a court finding; any close-out letter FDA lists is a row of its own. An untitled or FMD-145 letter states FDA’s view when it was issued.
FDA inspection classifications and published Form 483s
The FDA Data Dashboard, read Nov 15, 2026, lists One Way Drug, LLC, Las Vegas, NV (FEI number 3010839113); One Way Drug, Las Vegas, NV (FEI number 3011769075), matched to this page by exact name, city and state. It lists 2 inspections: 2 OAI at those sites, newest first, with FDA’s classification as worded on the dashboard. Dashboard firm profile (FEI 3010839113). Dashboard firm profile (FEI 3011769075).
| Inspection ended | Classification | Project area and product type | FEI | Inspection ID |
|---|---|---|---|---|
| Jul 19, 2017 | Official Action Indicated (OAI) | Drug Quality Assurance (Drugs) | 3010839113 | 1018429 |
| May 30, 2014 | Official Action Indicated (OAI) | Drug Quality Assurance (Drugs) | 3010839113 | 882562 |
Form 483s FDA has published for these sites
- Oct 2, 2017: Form 483 to One Way Drug, LLC, published Jan 17, 2024. fda.gov
- Jul 10, 2015: Form 483 to One Way Drug, LLC, published Jan 17, 2024. fda.gov
FDA classifies each inspection when it is closed: No Action Indicated (NAI) means no objectionable conditions were found or they did not justify further action; Voluntary Action Indicated (VAI) means objectionable conditions were found but FDA is not prepared to take or recommend regulatory action; Official Action Indicated (OAI) means FDA recommended regulatory or administrative action. A classification is FDA’s, not a finding by this site. The dashboard lists inspections once FDA has classified them, from fiscal year 2009 on, so a recent inspection may not appear yet.
Form 483 observations
A Form 483 lists an FDA investigator’s observations at the end of an inspection. It is not a final FDA determination. In FDA’s words: “The FDA Form 483 does not constitute a final Agency determination of whether any condition is in violation of the FD&C Act or any of its relevant regulations.” (FDA Form 483 FAQ). The firm may have answered or corrected these points; a response is not shown here unless FDA lists one.
FDA’s published Form 483 for this site has 3 numbered observations in all. Each observation is quoted from the PDF as FDA numbered it, with long ones cut and linked to the full form. Names of people on the form are not shown. What a Form 483 is; all 483s in this index.
Inspection Jul 17, 2017 to Jul 19, 2017: 3 observations
- Firm on the cover
- , Las Vegas, NV 89117-5481 '"'
- FEI number
- 3010839113
- Establishment type on the cover
- Producer of Non-sterile Drugs
- FDA district office on the cover
- 1431 Harbor Bay Parkway Alameda, CA 94502-7070
- Matched to this page by
- FEI number on the cover; linked from Data Dashboard
- FDA document
- Read the full 483 (PDF on fda.gov)
Observation 1
Written procedures are not established for the cleaning and maintenance ofe quipment, including utensils, used in the manufacture, processing, packing or holding of a drug product
Specifically, Your firm has not established written and approved procedures for the cleaning of equipment and utensils used in the preparation of drug products. During the inspection, we observed the cleaning of the following equipment and utensils used in non-sterile production of your drug products: <Redacted B4> blender for powders, capsule press, glassware, and spatulas. We observed your lab technician using <Redacted B4> to wash and rinse glassware. We additionally observed your lab technician using the vacuum cleaner to vacuum your <Redacted B4> brand powder press followed by wiping with <Redacted B4>. Your firm has no evidence to show that your cleaning procedures are adequate in the removal of residual products and the removal of sanitizing agents. ...
Observation 2
Drug products failing to meet established specifications are not rejected.
Specifically,
A. Your firm has not established written procedures to assure that expired finished products stored at your firm have the identity, strength, quality, and purity they purport to possess prior to releasing the product for patient use. The following expired finished products were not rejected and were observed stored in your firm's area for released finished products:
Finished Product
Lot#
Discard Date
BI /B2/B3/B5/B6,
20170407<@.31
DMSO in water
20170712@27
HCG, 200U/0.25 ml SL drops
20170505@58
Indole-3-carbinol 300 mg capsule
20161220@73
Betaine HCL/PEPSIN 250 mg/ I50mg
20170112@71
Trimix #4
Observation 3
Testing and release of drug product for distribution do not include appropriate laboratory determination of satisfactory conformance to the final specifications and identity and strength of each active ingredient prior to release.
Specifically,
A. Your firm has not established acceptable levels of microorganisms within each drug product. Your firm has also failed to test finished drug products for acceptable levels and the presence of objectionable microorganisms.
B. Your firm has not established written procedures for assay or potency testing ofyour finished drug products to assure they conform to appropriate specifications ofidentity, strength, quality, or purity. Your lab manager stated that there are no procedures, and that potency testing is conducted on a random schedule with randomly selected drug products.
or purity. Your lab manager stated that there are no procedures, and that potency testing is conducted on a random schedule with randomly selected drug products.
a. Specifically, your firm was notified that the potency of Estradiol was out-of-specification (OOS) at 114.1% and 114.901' respectfully (specification requirements <Redacted B4> for product, "Estra 0. ...
Linked 483s whose text is not shown
- Jul 10, 2015: FDA document 88497: the PDF is a scanned image with no readable text.
State board of pharmacy records
State board of pharmacy records for Nevada are not checked: no license file or list of board actions was found on the board’s website when checked on November 10, 2026 (it takes requests for discipline records); its license verification is an interactive search.
Nonresident licenses in other states
These boards list a nonresident license whose record names this pharmacy’s own name, city and state.
Texas State Board of Pharmacy, file dated Nov 15, 2026 (Texas).
| License | Type as the board gives it | Name on the board record | Location | Status | Prior disciplinary orders (file flag) |
|---|---|---|---|---|---|
| 26369 | Non-Resident (Not Located in Texas) | PARTELL SPECIALTY PHARMACY | LAS VEGAS, NV | Revocation | Yes |
Colorado State Board of Pharmacy, file dated Nov 15, 2026 (Colorado).
| License | Type as the board gives it | Name on the board record | Location | Status |
|---|---|---|---|---|
| OSP 6350 | OSP | Partell Specialty Pharmacy | Las Vegas, NV | Expired |
| OSP 6351 | OSP | Partell Specialty Pharmacy | Las Vegas, NV | Expired |
- Apr 22, 2026: “CLS Letter of Admonition”, license OSP 6351, case 2025-5663, Partell Specialty Pharmacy, Las Vegas, NV. Board document
Illinois Department of Financial and Professional Regulation, file dated Nov 13, 2026 (Illinois).
| License | Type as the board gives it | Name on the board record | Location | Status |
|---|---|---|---|---|
| 054018733 | LICENSED PHARMACY | ONE WAY DRUG LLC | LAS VEGAS, NV | CHANGE OF OWNERSHIP |
| 054018734 | LICENSED PHARMACY | ONE WAY DRUG LLC | LAS VEGAS, NV | CLOSED |
| 054020497 | LICENSED PHARMACY | ONE WAY DRUG LLC | LAS VEGAS, NV | NOT RENEWED |
| 054020655 | LICENSED PHARMACY | ONE WAY DRUG LLC | LAS VEGAS, NV | NOT RENEWED |
Connecticut Department of Consumer Protection, file dated Nov 15, 2026 (Connecticut).
| License | Type as the board gives it | Name on the board record | Location | Status |
|---|---|---|---|---|
| PCN.0002710 | NONRESIDENT PHARMACY | PARTELL SPECIALTY PHARMACY | LAS VEGAS, NV | INACTIVE |
| PCN.0003345 | NONRESIDENT PHARMACY | ONE WAY DRUG LLC (dba PARTEL SPECIALTY PHARMACY) | LAS VEGAS, NV | INACTIVE (EXPIRED MORE THAN 3 YEARS - MUST REAPPLY) |
Delaware Division of Professional Regulation, file dated Nov 10, 2026 (Delaware).
| License | Type as the board gives it | Name on the board record | Location | Status |
|---|---|---|---|---|
| A9-0002064 | Non Resident Pharmacy | Partell Specialty Pharmacy | LAS VEGAS, NV | Closed |
This page restates FDA’s lists and state board of pharmacy records. A Form 483, letter or board action is not a finding by this site, and a missing record is not a finding either way. A state license is matched only on the same name, city and state. Follow each link for the original document. Report an error or add a company response.
Sources
- FDA: Compounding: Inspections, Recalls, and other Actions
- FDA Registered Outsourcing Facilities (503B)
- FDA Data Dashboard: inspection classifications and published Form 483s
- FDA: FDA Form 483 Frequently Asked Questions
- Texas State Board of Pharmacy license file
- Colorado State Board of Pharmacy license file
- Illinois Department of Financial and Professional Regulation license file
- Connecticut Department of Consumer Protection license file
- Delaware Division of Professional Regulation license file
- Texas State Board of Pharmacy disciplinary records
- Delaware Division of Professional Regulation disciplinary records
Records last pulled Nov 15, 2026. Every entry links to the original public record.